Bactericidal activity of trovafloxacin (CP-99,219)

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 6, 1996, Pages 1061-1066

  Morrissey, Ian ^a,b  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FLUOROQUINOLONES; KINETICS; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030450995     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.6.1061     Document Type: Article

References (16)

1. Gootz, T. D., Brighty, K. E., Anderson, M. R., Schmieder, B. J., Haskell, S. L., Sutcliffe, J. A. et al. (1994), In-vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial. Diagnostic Microbiology and Infectious Diseases 19, 235-43.
2. Lewin, C. S. (1992). Antibacterial activity of a 1,8-naphthyridine quinolone, PD131628. Journal of Medical Microbiology 36, 353-7.
3. Lewin, C. S. & Amyes, S. G. B. (1989). The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. Journal of Medical Microbiology 30, 227-31.
4. Lewin, C. S. & Amyes, S. G. B. (1990a). Bactericidal action of PD 127,391, an enhanced spectrum quinolone. Journal of Medical Microbiology 33, 67-70.
5. Lewin, C. S. & Amyes, S. G. B. (1990b). Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL16. Journal of Medical Microbiology 32, 83-6.
6. Lewin, C. S., Amyes, S. G. B. & Smith, J. T. (1989). Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16. European Journal of Clinical Microbiology and Infectious Diseases 8, 731-3.
7. Lewin, C. S., Morrissey, I. & Smith, J. T. (1991a). The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment. European Journal of Clinical Microbiology and Infectious Diseases 10, 240-8.
8. Lewin, C. S., Morrissey, I. & Smith, J. T. (1991b). The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis. Journal of Pharmacy and Pharmacology 43, 492-4.
9. Lewin, C. S., Morrissey, I. & Smith, J. T. (1992). The bactericidal activity of sparfloxacin. Journal of Antimicrobial Chemotherapy 30, 625-32.
10. Lewin, C. S. & Smith, J. T. (1988). Bactericidal mechanisms of ofloxacin. Journal of Antimicrobial Chemotherapy 22, Suppl. C, 1-8.
11. Morrissey, I. & Smith, J. T. (1993). Activity of quinolone antibacterials against Streptococcus pneumoniae. Drugs 45, Suppl. 3, 196-7.
12. Morrissey, I. & Smith, J. T. (1994). Activity of 4-quinolones against Pseudomonas aeruginosa. Arzneimittel Forschung Drug Research 44, 1157-61.
13. Morrissey, I. & Smith, J. T. (1995). Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a. Journal of Medical Microbiologv 43, 4-8.
14. Paris, M. M., Hickey, S. M., Trujillo, M., Shelton, S. & McCracken, G. H. (1995). Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 39, 1243-6.
15. Ratcliffe, N. T. & Smith, J. T. (1985). Norfloxacin has a novel bactericidal mechanism unrelated to that of other 4-quinolones. Journal of Pharmacy and Pharmacology 37, Suppl., 92P.
16. Smith, J. T. & Lewin, C. S. (1988). Chemistry and mechanisms of action of the quinolone antibacterials. In The Quinolones (Andriole, V. T., Ed.), pp. 23-82. Academic Press, London.